Anti-VEGFC antibody produced in mouse
SIGMA/SAB1411757 - purified immunoglobulin, buffered aqueous solution
Synonym: Flt4-L; VRP
Product Type: Chemical
Western Blotting Western Blot analysis of VEGFC expression in transfected 293T cell line by VEGFC polyclonal antibody. Lanes Lane 1: VEGFC transfected lysate (46.09 kDa). Lane 2: Non-transfected lysate.
| antibody form | purified immunoglobulin |
| antibody product type | primary antibodies |
| biological source | mouse |
| clone | polyclonal |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| mol wt | antigen 46.09 kDa |
| NCBI accession no. | DQ894481.2   |
| Quality Level | 100 |
| shipped in | dry ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | western blot: 1 μg/mL |
| UniProt accession no. | P49767 |
| Biochem/physiol Actions: | VEGF-C (vascular endothelial growth factor-C) has a role in lymphangiogenesis. It functions through the VEGF receptor-3 (VEGFR-3). Experimental studies have shown that VEGF-C is required for lymphatic endothelial cells to form sprouting capillaries. VEGF-C expression has been observed in breast cancer, prostatic cancer, gastric cancer, colon cancer and lung cancer. |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| General description: | The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor D. (provided by RefSeq) |
| General description: | The vascular endothelial growth factor-C (VEGF-C) gene with seven exons is mapped to human chromosome 4q34.3. It is a member of the VEGF family of structurally related proteins. Members of the family contain a common VEGF homology domain. This domain forms the core region and contains a cystine knot motif with eight invariant cysteine residues. In adults, VEGF-C is mainly expressed in heart, placenta, ovary, small intestine and the thyroid gland, whereas in embryonic tissue, it is expressed in the perimetanephric, axillary and jugular areas. |
| Immunogen: | VEGFC (ABM85407.1, 1 a.a. ~ 419 a.a) full-length human protein. Sequence MHLLGFFSVACSLLAAALLPGPREA |
| Physical form: | Solution in phosphate buffered saline, pH 7.4 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |